Albemarle Corporation (NYSE:ALB – Get Free Report) reached a new 52-week high during trading on Wednesday after Mizuho raised their price target on the stock from $110.00 to $132.00. Mizuho currently has a neutral rating on the stock. Albemarle traded as high as $137.94 and last traded at $138.4950, with a volume of 625106 shares traded. The stock had previously closed at $131.07.
Other equities research analysts have also issued reports about the stock. Royal Bank Of Canada reissued an “outperform” rating and issued a $159.00 target price on shares of Albemarle in a report on Thursday. Rothschild & Co Redburn increased their price objective on shares of Albemarle from $135.00 to $158.00 and gave the stock a “buy” rating in a research note on Thursday, December 4th. Bank of America restated a “neutral” rating and set a $100.00 price objective (up from $95.00) on shares of Albemarle in a research report on Tuesday, October 14th. Wells Fargo & Company lifted their target price on shares of Albemarle from $90.00 to $100.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 11th. Finally, Robert W. Baird set a $113.00 price target on Albemarle and gave the stock a “neutral” rating in a research note on Tuesday, December 2nd. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, eighteen have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $118.75.
Check Out Our Latest Stock Report on Albemarle
Institutional Trading of Albemarle
Albemarle Price Performance
The company has a current ratio of 2.27, a quick ratio of 1.51 and a debt-to-equity ratio of 0.40. The firm’s 50-day moving average price is $111.93 and its 200-day moving average price is $87.42. The stock has a market capitalization of $16.53 billion, a PE ratio of -88.33 and a beta of 1.43.
Albemarle (NYSE:ALB – Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The specialty chemicals company reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.92) by $0.73. The company had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.27 billion. Albemarle had a positive return on equity of 0.10% and a negative net margin of 0.43%.The firm’s revenue for the quarter was down 3.5% on a year-over-year basis. During the same period in the previous year, the firm posted ($1.55) earnings per share. On average, equities analysts forecast that Albemarle Corporation will post -0.04 EPS for the current fiscal year.
Albemarle Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Investors of record on Friday, December 12th will be given a $0.405 dividend. The ex-dividend date is Friday, December 12th. This represents a $1.62 dividend on an annualized basis and a yield of 1.2%. Albemarle’s dividend payout ratio (DPR) is currently -101.89%.
Albemarle Company Profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
See Also
- Five stocks we like better than Albemarle
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Broadcom Stock Crashes 20%—But Wall Street Sees It Soaring to $500
- Compound Interest and Why It Matters When Investing
- Forget the Chips: 4 Industrial Plays for the AI Rebound
- 3 Monster Growth Stocks to Buy Now
- MongoDB Could Hit Record Highs—But You’ll Need to Move Fast
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.
